Study findings reveals a 1-way relationship between cardiovascular disease and psoriasis, with no impact on other ...

Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

Brodalumab is an effective therapy among patients with psoriasis who have failed prior biologic therapy or had risk factors for treatment failure.

The actress and entertainment personality partnered with Amgen to share candid glimpses of how she lives with her medical ...

InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...

A variety of treatments exist if you ... impacting your daily life. Psoriasis increases your risk for type 2 diabetes, cardiovascular (heart) disease, depression, and psoriatic arthritis (PsA).

Plaque psoriasis is a chronic condition that affects millions yet is often misunderstood or underappreciated in terms of its ...

Alex Thompson CFA, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Oruka Therapeutics (ORKA). Alex Thompson CFA has given ...

InnoCare Pharma’s tyrosine kinase 2 (TYK2) inhibitor has hit the main goals of a phase 2 trial in China, sustaining the ...